TIAP’s President & CEO, Parimal Nathwani, is appointed to the Government of Canada’s COVID-19 Core Task Force to advise on funding of new and potential therapies for COVID-19:
https://www.ic.gc.ca/eic/site/lsg-pdsv.nsf/eng/hn01780.htmlÂ
News